In conclusion, the present study indicated that miRNA-15a acted in concert with fludarabine to exert synergistic anticancer efficacy against chronic lymphocytic leukemia, which attributed to the down-regulation of Mcl-1 and Bcl-2. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.